These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2971496)

  • 1. Inhibition of polymorphonuclear leukocyte chemotaxis by the mucoid exopolysaccharide of Pseudomonas aeruginosa.
    Stiver HG; Zachidniak K; Speert DP
    Clin Invest Med; 1988 Aug; 11(4):247-52. PubMed ID: 2971496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
    LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T
    Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB
    Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa.
    Pier GB; Elcock ME
    J Immunol; 1984 Aug; 133(2):734-9. PubMed ID: 6234359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
    Holby N; Olling S
    Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
    Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
    N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal B cell stimulation and interleukin 1 induction by the mucoid exopolysaccharide of Pseudomonas aeruginosa associated with cystic fibrosis.
    Daley L; Pier GB; Liporace JD; Eardley DD
    J Immunol; 1985 May; 134(5):3089-93. PubMed ID: 3920310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mucoid and non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients on inflammatory mediator release from human polymorphonuclear granulocytes and rat mast cells.
    Friedl P; König B; König W
    Immunology; 1992 May; 76(1):86-94. PubMed ID: 1321094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to Pseudomonas aeruginosa mucoid exopolysaccharide and to sodium alginate in cystic fibrosis serum.
    Speert DP; Lawton D; Mutharia LM
    Pediatr Res; 1984 May; 18(5):431-3. PubMed ID: 6233529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of serum opsonic activity in cystic fibrosis with colonization and disease state: measurement of opsonins to Pseudomonas aeruginosa by neutrophil superoxide anion generation.
    Bender JG; Florman AL; Van Epps DE
    Pediatr Res; 1987 Oct; 22(4):383-8. PubMed ID: 2825106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
    Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
    Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.
    Pier GB; Grout M; Desjardins D
    J Immunol; 1991 Sep; 147(6):1869-76. PubMed ID: 1832427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response of rabbits and cystic fibrosis patients to an alginate-specific outer membrane protein of a mucoid strain of Pseudomonas aeruginosa.
    Rehm BH; Grabert E; Hein J; Winkler UK
    Microb Pathog; 1994 Jan; 16(1):43-51. PubMed ID: 8057826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa.
    Pier GB; Matthews WJ; Eardley DD
    J Infect Dis; 1983 Mar; 147(3):494-503. PubMed ID: 6220094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
    Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
    Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.
    Pier GB; Takeda S; Grout M; Markham RB
    J Clin Invest; 1993 Mar; 91(3):1079-87. PubMed ID: 8450038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of nutrient media on the characteristics of the exopolysaccharide produced by three mucoid Pseudomonas aeruginosa strains.
    Buckmire FL
    Microbios; 1984; 41(163):49-63. PubMed ID: 6441885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.